Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations. - Lu T; Hamidi H; Socinski MA; Reck M; Cappuzzo F; Barlesi F; Jotte RM; Müller S; Qamra A; Amitai A; Guan X; Fuentes E; et al. (Nature communications, 2025)